Analystreport

CytomX Therapeutics, Inc. (NASDAQ: CTMX) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "overweight" rating.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com